发明名称 |
NOVEL HSP90-TARGETED ANTI-CANCER CHIMERIC PEPTIDE |
摘要 |
<p>Disclosed is a substance which is not accumulated stably in cells, does not cause the dysfunction of normal cells, and so on, and therefore can be used as an anti-cancer agent or a DDS having no adverse side effect. It is found that Hsp90 alone cannot exhibit a chaperon function that can assist the refolding of a protein such as surviving, but can exhibit the function when Hop (which is one of partner proteins of Hsp90) binds to Hsp90. Thus, specifically disclosed is a chimeric peptide comprising an Hsp90 TPR domain binding peptide and a cell-penetrating peptide.</p> |
申请公布号 |
WO2010055929(A1) |
申请公布日期 |
2010.05.20 |
申请号 |
WO2009JP69405 |
申请日期 |
2009.11.13 |
申请人 |
KYOTO UNIVERSITY;KAWAKAMI KOJI;KOHNO MASAYUKI;HORIBE TOMOHISA |
发明人 |
KAWAKAMI KOJI;KOHNO MASAYUKI;HORIBE TOMOHISA |
分类号 |
C12N15/09;A61K9/127;A61K38/00;A61K45/00;A61K47/48;A61P35/00;A61P43/00;C07K7/08;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;G01N33/15;G01N33/50 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|